Production (Stage)
Aquestive Therapeutics, Inc.
AQST
$2.35
$0.062.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -27.88% | 199.71% | 212.61% | 300.56% | 254.14% |
| Total Receivables | 25.47% | -13.30% | 13.26% | -40.62% | 10.24% |
| Inventory | -6.93% | -10.71% | -0.82% | 17.08% | 10.79% |
| Prepaid Expenses | 35.31% | 77.24% | 3.19% | -9.53% | -7.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.35% | 115.35% | 127.45% | 161.41% | 159.41% |
|
|
|||||
| Total Current Assets | -21.35% | 115.35% | 127.45% | 161.41% | 159.41% |
| Net Property, Plant & Equipment | -6.72% | -7.75% | -10.39% | -9.87% | -2.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -100.00% | -100.00% | -100.00% | -11.25% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.19% | -22.34% | -22.44% | -22.51% | -16.47% |
| Total Assets | -21.07% | 76.64% | 84.97% | 106.35% | 111.35% |
|
|
|||||
| Total Accounts Payable | 16.70% | 15.25% | -24.23% | -46.71% | -15.41% |
| Total Accrued Expenses | -26.61% | -7.74% | -8.10% | 33.10% | 2.86% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 29.75% | 30.10% | -89.80% | -97.44% | -97.51% |
| Total Finance Division Other Current Liabilities | -16.78% | -17.19% | -43.46% | -59.01% | -58.37% |
| Total Other Current Liabilities | -16.78% | -17.19% | -43.46% | -59.01% | -58.37% |
| Total Current Liabilities | 1.33% | 3.04% | -37.02% | -64.05% | -55.28% |
|
|
|||||
| Total Current Liabilities | 1.33% | 3.04% | -37.02% | -64.05% | -55.28% |
| Long-Term Debt | 17.54% | 18.36% | -10.00% | 43.48% | 13.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.01% | -8.22% | -4.48% | -3.78% | -4.47% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -6.53% | -6.60% | 5.71% | 5.44% | 14.60% |
| Total Liabilities | -1.60% | -1.42% | -4.31% | -6.45% | -2.75% |
|
|
|||||
| Common Stock & APIC | 10.02% | 42.56% | 44.56% | 47.90% | 52.45% |
| Retained Earnings | -16.34% | -13.83% | -11.32% | -8.33% | -9.49% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -67.85% | 43.51% | 55.87% | 66.73% | 66.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -67.85% | 43.51% | 55.87% | 66.73% | 66.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -67.85% | 43.51% | 55.87% | 66.73% | 66.77% |
|
|
|||||